Regeneron Ireland DAC, 7.14% 31dec2027, USD (IE00BJ5JSL15, WKN A2R1F8)
国内債券, Senior Subordinated Unsecured
国内債券, Senior Subordinated Unsecured
|
Regeneron Ireland Designated Activity Company is a leading science and technology company delivering life-transforming treatments for serious diseases. Founded by physician-scientists over 30 years ago, its science-driven approach has resulted in nine FDA-approved medicines, eight EMA-approved ...
Regeneron Ireland Designated Activity Company is a leading science and technology company delivering life-transforming treatments for serious diseases. Founded by physician-scientists over 30 years ago, its science-driven approach has resulted in nine FDA-approved medicines, eight EMA-approved medicines and numerous product candidates in a range of diseases, including asthma, pain, cancer and infectious diseases.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡